AJP - Renal Physiology, Vol 264, Issue 6 1032-F1037, Copyright © 1993 by American Physiological Society

ARTICLES

cAMP-independent, G protein-linked inhibition of Na+/H+ exchange in renal brush border by D1 dopamine agonists

C. C. Felder, F. E. Albrecht, T. Campbell, G. M. Eisner and P. A. Jose
Section on Pharmacology, National Institute of Mental Health, Bethesda, Maryland 20892.

When D1 dopamine agonists are incubated with renal cortical tissue, Na+/H+ exchange activity is inhibited, presumably due to D1 receptor-mediated stimulation of adenylyl cyclase and subsequent increase in protein kinase A activity. Although the role of adenosine 3',5'-cyclic monophosphate (cAMP) and cAMP-dependent protein kinase in the regulation of Na+/H+ exchange activity is well established, receptors functionally coupled to adenylyl cyclase can regulate Na+/H+ exchange activity independently of changes of cAMP accumulation. The current studies were designed to determine whether D1 agonists can inhibit Na+/H+ exchange activity independently of changes of cAMP accumulation and also to determine the role of G proteins in this process. The D1 agonist, fenoldopam, inhibited Na+/H+ exchange activity in a time-related and concentration-dependent manner. The 50% inhibitory concentration was 5-34 microM. Occupation of the renal D1 receptor mediates this action, since the D1 antagonist, SKF 83742, partially blocks the effect. This action, however, was independent of adenylyl cyclase, protein kinase A, and protein kinase C activity. Inhibition of adenylyl cyclase with dideoxyadenosine or inhibition of protein kinase A and C with the isoquinolines N-(2-guanidinoethyl)-5-isoquinolinesulfonamide hydrochloride (H-4) and 1-(5-isoquinolinesfulfonyl)-2-methylpiperazine (H-7) did not block the effect of fenoldopam on the exchanger. The action of fenoldopam is not due to an amiloride-like action on the exchanger, because kinetic analysis of the inhibitory action was noncompetitive and the effect of fenoldopam was time dependent. The process involved G proteins, since guanosine 5'-O-(2-thiodiphosphate) prevented while guanosine 5'-O-(3-thiotriphosphate) increased the inhibitory effect of fenoldopam.

This article has been cited by other articles:

				C. Zeng, H. Sanada, H. Watanabe, G. M. Eisner, R. A. Felder, and P. A. Jose Functional genomics of the dopaminergic system in hypertension Physiol Genomics, November 17, 2004; 19(3): 233 - 246. [Abstract] [Full Text] [PDF]

				R. Pedrosa, P. Gomes, U. Hopfer, P. A. Jose, and P. Soares-da-Silva Gi{alpha}3 protein-coupled dopamine D3 receptor-mediated inhibition of renal NHE3 activity in SHR proximal tubular cells is a PLC-PKC-mediated event Am J Physiol Renal Physiol, November 1, 2004; 287(5): F1059 - F1066. [Abstract] [Full Text] [PDF]

				S. Zheng, P. Yu, C. Zeng, Z. Wang, Z. Yang, P. M. Andrews, R. A. Felder, and P. A. Jose G{alpha}12- and G{alpha}13-Protein Subunit Linkage of D5 Dopamine Receptors in the Nephron Hypertension, March 1, 2003; 41(3): 604 - 610. [Abstract] [Full Text] [PDF]

				T. Hussain and M. F. Lokhandwala Renal Dopamine Receptors and Hypertension Experimental Biology and Medicine, February 1, 2003; 228(2): 134 - 142. [Abstract] [Full Text] [PDF]

				E. Feraille and A. Doucet Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control Physiol Rev, January 1, 2001; 81(1): 345 - 418. [Abstract] [Full Text] [PDF]

				J. Xu, X. X. Li, F. E. Albrecht, U. Hopfer, R. M. Carey, and P. A. Jose Dopamine1 Receptor, Gs{alpha}, and Na+-H+ Exchanger Interactions in the Kidney in Hypertension Hypertension, September 1, 2000; 36(3): 395 - 399. [Abstract] [Full Text] [PDF]

				X. X. Li, F. E. Albrecht, J. E. Robillard, G. M. Eisner, and P. A. Jose Gbeta regulation of Na/H exchanger-3 activity in rat renal proximal tubules during development Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2000; 278(4): R931 - R936. [Abstract] [Full Text] [PDF]

				F. E. Albrecht, J. Xu, O. W. Moe, U. Hopfer, W. F. Simonds, J. Orlowski, and P. A. Jose Regulation of NHE3 activity by G protein subunits in renal brush-border membranes Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2000; 278(4): R1064 - R1073. [Abstract] [Full Text] [PDF]

				T. Hussain and M. F. Lokhandwala Renal Dopamine Receptor Function in Hypertension Hypertension, August 1, 1998; 32(2): 187 - 197. [Abstract] [Full Text] [PDF]

				C. MISSALE, S. R. NASH, S. W. ROBINSON, M. JABER, and M. G. CARON Dopamine Receptors: From Structure to Function Physiol Rev, January 1, 1998; 78(1): 189 - 225. [Abstract] [Full Text] [PDF]

				J. Harvey and M. G. Lacey A Postsynaptic Interaction between Dopamine D1 and NMDA Receptors Promotes Presynaptic Inhibition in the Rat Nucleus Accumbens via Adenosine Release J. Neurosci., July 15, 1997; 17(14): 5271 - 5280. [Abstract] [Full Text] [PDF]

				E. Friedman, L.-Q. Jin, G.-P. Cai, T. R. Hollon, J. Drago, D. R. Sibley, and H.-Y. Wang D1-like Dopaminergic Activation of Phosphoinositide Hydrolysis Is Independent of D1A Dopamine Receptors: Evidence from D1A Knockout Mice Mol. Pharmacol., January 1, 1997; 51(1): 6 - 11. [Abstract] [Full Text]

				P.-Y. Yu, GilbertM. Eisner, I. Yamaguchi, M.M. Mouradian, RobinA. Felder, and PedroA. Jose Dopamine D1A Receptor Regulation of Phospholipase C Isoform J. Biol. Chem., August 9, 1996; 271(32): 19503 - 19508. [Abstract] [Full Text] [PDF]